Xtant Medical Holdings Inc（以下简称“Xtant Medical”）今日宣布，已与Biohorizons缔结独家战略合作伙伴关系，旨在进一步扩大其同种异体生长因子在牙科领域的市场覆盖与应用范围。此次合作标志着Xtant Medical在生物再生医学领域迈出重要一步，有望显著增强其在牙科细分市场中的竞争力与渗透力。
Xtant Medical Holdings Inc（以下简称“Xtant Medical”）今日宣布，已与Biohorizons缔结独家战略合作伙伴关系，旨在进一步扩大其同种异体生长因子在牙科领域的市场覆盖与应用范围。此次合作标志着Xtant Medical在生物再生医学领域迈出重要一步，有望显著增强其在牙科细分市场中的竞争力与渗透力。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.